KR102298782B1 - Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof - Google Patents
Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof Download PDFInfo
- Publication number
- KR102298782B1 KR102298782B1 KR1020200151783A KR20200151783A KR102298782B1 KR 102298782 B1 KR102298782 B1 KR 102298782B1 KR 1020200151783 A KR1020200151783 A KR 1020200151783A KR 20200151783 A KR20200151783 A KR 20200151783A KR 102298782 B1 KR102298782 B1 KR 102298782B1
- Authority
- KR
- South Korea
- Prior art keywords
- concentration
- sewage
- solvent
- extract
- strain
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 81
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 241001289529 Fallopia multiflora Species 0.000 title 1
- 239000010865 sewage Substances 0.000 claims abstract description 134
- 238000000855 fermentation Methods 0.000 claims abstract description 82
- 230000004151 fermentation Effects 0.000 claims abstract description 82
- 239000002904 solvent Substances 0.000 claims description 63
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 57
- 241001608472 Bifidobacterium longum Species 0.000 claims description 45
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 45
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000004480 active ingredient Substances 0.000 claims description 17
- 150000001298 alcohols Chemical class 0.000 claims description 11
- 235000015872 dietary supplement Nutrition 0.000 claims description 9
- 239000002537 cosmetic Substances 0.000 claims description 8
- 230000003078 antioxidant effect Effects 0.000 abstract description 20
- 238000000034 method Methods 0.000 abstract description 10
- 235000015096 spirit Nutrition 0.000 description 56
- 240000002605 Lactobacillus helveticus Species 0.000 description 39
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 39
- 229940054346 lactobacillus helveticus Drugs 0.000 description 39
- 230000000052 comparative effect Effects 0.000 description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 13
- 230000002292 Radical scavenging effect Effects 0.000 description 12
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000007760 free radical scavenging Effects 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 125000003158 alcohol group Chemical group 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 235000021108 sauerkraut Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A23Y2220/39—
-
- A23Y2240/75—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 하수오 발효추출 조성물 및 이의 제조방법에 관한 것으로, 더욱 상세하게는 소정의 균주를 통한 발효로 인해 항산화성이 현저히 우수한 효과를 나타내는 하수오 발효추출 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to a fermented sewage extract composition and a method for preparing the same, and more particularly, to a fermented sewage extract composition and a method for preparing the same, which exhibit remarkably excellent antioxidative effects due to fermentation through a predetermined strain.
Description
본 발명은 하수오 발효추출 조성물 및 이의 제조방법에 관한 것으로, 더욱 상세하게는 소정의 균주를 통한 발효로 인해 항산화성이 현저히 우수한 효과를 나타내는 하수오 발효추출 조성물 및 이의 제조방법에 관한 것이다.The present invention relates to a fermented sewage extract composition and a method for preparing the same, and more particularly, to a fermented sewage extract composition and a method for preparing the same, which exhibit remarkably excellent antioxidative effects due to fermentation through a predetermined strain.
최근 천연식물체를 중심으로 한 연구가 발전하면서 이들이 가지는 생리활성 물질에 대한 관심이 증대되고 있다. 생리활성 물질은 적은 양으로 현저한 활성을 나타내는 고부가치 물질이기에 새로운 물질들의 연구, 개발이 활발히 이루어지고 있다.Recently, with the development of research centered on natural plants, interest in the physiologically active substances they have is increasing. Since bioactive substances are high value-added substances that show remarkable activity in small amounts, research and development of new substances are being actively carried out.
특히 인공합성물질 중 일부에 대한 안전성 문제들이 제기되고, 사람들의 건강에 대한 관심과 욕구 증대에 따라 천연 생리활성 물질에 대한 관심은 더욱 증가할 것으로 보인다. 따라서 식품학, 영양학, 약학 등의 연구분야에서는 다양한 천연 식물체 내에 존재하는 여러 화합물들의 생물학적 활성 평가가 이루어지고 있으며, 그 중 항산화 활성에 관한 연구에 관심이 집중되고 있다.In particular, safety issues for some of the artificial synthetic materials are raised, and interest in natural bioactive materials is expected to increase as people's interest and desire for health increase. Therefore, in research fields such as food science, nutrition, and pharmaceuticals, the biological activity of various compounds present in various natural plants is evaluated, and among them, research on antioxidant activity is focused.
생물체의 산화스트레스로 인한 산화물이 노화를 비롯한 암, 동맥경화 등의 각종 만성 퇴행성 질환의 발생원인으로 밝혀지면서 이를 조절하는데 관여하는 천연 항산화 물질의 가치가 부각되고 있다.As oxides caused by oxidative stress in living things are found to be the cause of various chronic degenerative diseases such as aging, cancer, and arteriosclerosis, the value of natural antioxidants involved in controlling them is being highlighted.
일반적으로 항산화제는 인체에서 세포막의 산화 등을 저해하여, 노화 등의 예방에 유익한 성분으로 알려졌으나, 기존의 합성 항산화제는 천연물에 비해서 인체독성이 있는 관계로 식품 등 인간의 섭취물에 인공적으로 첨가되는 첨가제로 사용하기에는 문제가 있어, 최근 천연 항산화제의 추출, 분리를 위한 연구가 활발히 진행되고 있다.In general, antioxidants are known as beneficial ingredients for the prevention of aging by inhibiting the oxidation of cell membranes in the human body. There is a problem in using it as an added additive, so research for extraction and separation of natural antioxidants is being actively conducted.
종래에는 탈지미강을 물과 에탄올 혼합액으로 추출하여 얻은 추출액을 여과, 농축한 다음 항산화제를 제조하는 방법을 통해 항산화성 향상을 도모하였으나, 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있었다.Conventionally, antioxidative properties were improved by filtering and concentrating the extract obtained by extracting defatted rice bran with a mixture of water and ethanol, and then preparing an antioxidant, but there was a problem in that antioxidant properties could not be expressed to a desired level.
이에, 항산화성이 현격히 우수한 효과를 나타낼 수 있는 물질에 대한 연구가 시급한 실정이다.Accordingly, there is an urgent need to study a substance capable of exhibiting a remarkably excellent effect of antioxidant properties.
본 발명은 상술한 문제점을 해결하기 위해 안출된 것으로, 소정의 균주를 통한 발효로 인해 항산화성이 현저히 우수한 효과를 나타내는 하수오 발효추출 조성물 및 이의 제조방법을 제공하는데 목적이 있다.The present invention has been devised to solve the above-described problems, and an object of the present invention is to provide a composition for extracting fermented sewage which exhibits a remarkably excellent effect in antioxidant properties due to fermentation through a predetermined strain, and a method for preparing the same.
상술한 과제를 해결하기 위해 본 발명은, 하수오를 물, 농도가 15 ~ 45%인 C1 ~ C4의 알콜 및 농도가 55 ~ 85%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종을 포함하는 제1용매를 통해 추출한 하수오 추출물을, 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 스트렙토코커스 써모필러스(Streptococcus thermophilus) 및 비피도박테리움 롱검(Bifidobacterium longum)으로 이루어진 군에서 선택된 1종 이상을 포함하는 균주로 발효시킨 하수오 발효추출물;을 유효성분으로 포함하는 하수오 발효추출 조성물을 제공한다.In order to solve the above problems, the present invention includes one selected from the group consisting of sewage water, C1 to C4 alcohols having a concentration of 15 to 45%, and C1 to C4 alcohols having a concentration of 55 to 85%. The sewage extract extracted through the first solvent, comprising at least one selected from the group consisting of Lactobacillus helveticus, Streptococcus thermophilus and Bifidobacterium longum It provides a sewage fermentation extract composition comprising a; sewage fermentation extract fermented with a strain as an active ingredient.
본 발명의 일 실시예에 의하면, 상기 제1용매가 물이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus) 또는 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출물을 30 ~ 420㎍/㎖의 농도로 포함할 수 있다.According to an embodiment of the present invention, when the first solvent is water, and the strain is Lactobacillus helveticus or Bifidobacterium longum, 30 ~ 420 It may be included at a concentration of μg/ml.
또한, 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus)인 경우, 상기 하수오 발효추출물을 1 ~ 210㎍/㎖의 농도로 포함할 수 있다.In addition, when the first solvent is an alcohol of C1 to C4 having a concentration of 15 to 45%, and the strain is Lactobacillus helveticus, the sewage fermentation extract is used at a concentration of 1 to 210 μg/ml. may include
또한, 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 스트렙토코커스 써모필러스(Streptococcus thermophilus)인 경우, 상기 하수오 발효추출물을 30 ~ 60㎍/㎖의 농도로 포함할 수 있다.In addition, when the first solvent is a C1 to C4 alcohol having a concentration of 15 to 45%, and the strain is Streptococcus thermophilus, the fermented sewage extract is used at a concentration of 30 to 60 μg/ml. may include
또한, 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출물을 30 ~ 150㎍/㎖의 농도로 포함할 수 있다.In addition, when the first solvent is a C1 to C4 alcohol having a concentration of 15 to 45%, and the strain is Bifidobacterium longum, the fermented sewage extract is used at a concentration of 30 to 150 μg/ml. may include
또한, 상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus)인 경우, 상기 하수오 발효추출물을 3 ~ 8㎍/㎖의 농도로 포함할 수 있다.In addition, when the first solvent is an alcohol of C1 to C4 having a concentration of 55 to 85%, and the strain is Lactobacillus helveticus, the sewage fermentation extract is used at a concentration of 3 to 8 μg/ml. may include
또한, 상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출물을 80 ~ 130㎍/㎖의 농도로 포함할 수 있다.In addition, when the first solvent is a C1 to C4 alcohol having a concentration of 55 to 85%, and the strain is Bifidobacterium longum, the fermented sewage extract is used at a concentration of 80 to 130 μg/ml. may include
또한, 상기 발효는 온도 25 ~ 45℃에서 35 ~ 61시간 동안 수행할 수 있다.In addition, the fermentation may be performed at a temperature of 25 to 45° C. for 35 to 61 hours.
또한, 상기 락토바실러스 헬베티쿠스(Lactobacillus helveticus)는 기탁번호가 KACC91148일 수 있고, 상기 스트렙토코커스 써모필러스(Streptococcus thermophilus)는 기탁번호가 KACC91147일 수 있으며, 상기 비피도박테리움 롱검(Bifidobacterium longum)은 기탁번호가 KACC91563일 수 있다.In addition, the Lactobacillus helveticus may have an accession number KACC91148, the Streptococcus thermophilus may have an accession number KACC91147, and the Bifidobacterium longum may be The accession number may be KACC91563.
한편, 본 발명은 (1) 하수오를 물, 농도가 15 ~ 45%인 C1 ~ C4의 알콜 및 농도가 55 ~ 85%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종을 포함하는 제1용매를 통해 추출하여 하수오 추출물을 제조하는 단계; (2) 상기 하수오 추출물을 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 스트렙토코커스 써모필러스(Streptococcus thermophilus) 및 비피도박테리움 롱검(Bifidobacterium longum)으로 이루어진 군에서 선택된 1종 이상을 포함하는 균주로 발효시켜서 하수오 발효추출물을 제조하는 단계; (3) 상기 하수오 발효추출물을 유효성분으로 포함하는 하수오 발효추출 조성물을 제조하는 단계;를 포함하는 하수오 발효추출 조성물 제조방법을 제공한다.On the other hand, the present invention provides a first solvent comprising one selected from the group consisting of (1) sewage water, a C1-C4 alcohol having a concentration of 15 to 45%, and a C1-C4 alcohol having a concentration of 55 to 85%. Extracting through to prepare a sewage extract; (2) Fermentation of the sewage extract into a strain containing at least one selected from the group consisting of Lactobacillus helveticus, Streptococcus thermophilus and Bifidobacterium longum to prepare a sewage fermentation extract; (3) preparing a sewage fermentation extract composition comprising the sewage fermentation extract as an active ingredient; provides a method for preparing a sewage fermentation extract composition comprising.
한편, 본 발명은 상술한 하수오 발효추출 조성물;을 유효성분으로 포함하는 화장료 조성물을 제공한다.On the other hand, the present invention provides a cosmetic composition comprising the above-mentioned sewage fermentation extract composition; as an active ingredient.
한편, 본 발명은 상술한 하수오 발효추출 조성물;을 유효성분으로 포함하는 건강 보조 식품을 제공한다.On the other hand, the present invention provides a health supplement comprising; as an active ingredient;
한편, 본 발명은 상술한 하수오 발효추출 조성물;을 유효성분으로 포함하는 약학적 조성물을 제공한다.On the other hand, the present invention provides a pharmaceutical composition comprising the above-mentioned sewage fermentation extract composition; as an active ingredient.
본 발명의 하수오 발효추출 조성물 및 이의 제조방법은 소정의 균주를 통한 발효로 인해 항산화성이 현저히 우수한 효과를 발현할 수 있다.The fermented sewage extract composition of the present invention and a method for producing the same can express a remarkably excellent effect of antioxidant properties due to fermentation through a predetermined strain.
도 1 내지 도 3은 하수오의 추출 용매와 발효 균주에 따른 DPPH 항산화성 실험결과 그래프, 그리고,
도 4 내지 도 6은 하수오의 추출 용매와 발효 균주에 따른 ABTS 항산화성 실험결과 그래프이다.1 to 3 are graphs of DPPH antioxidant activity test results according to the extraction solvent and fermentation strain of Hsuo, and,
4 to 6 are graphs of the results of the ABTS antioxidant experimentation according to the extraction solvent and fermentation strain of Hawthorn.
이하 본 발명의 실시예에 대하여 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 상세히 설명한다. 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.Hereinafter, embodiments of the present invention will be described in detail so that those of ordinary skill in the art to which the present invention pertains can easily implement them. The present invention may be embodied in many different forms and is not limited to the embodiments described herein.
본 발명의 일 실시예에 따른 하수오 발효추출 조성물은, 하수오를 제1용매를 통해 추출한 하수오 추출물을, 균주로 발효시킨 하수오 발효추출물;을 유효성분으로 포함하여 구현 된다.The sewage fermentation extract composition according to an embodiment of the present invention is implemented by including, as an active ingredient, a sewage sewage extract obtained by extracting sewage from a first solvent, and a sewage fermentation extract fermented with a strain.
먼저, 상기 하수오 추출물에 대하여 설명한다.First, the sewage extract will be described.
상기 하수오 추출물은 하수오를 제1용매를 통해 추출하여 제조한다.The sewage extract is prepared by extracting sewage through a first solvent.
이때, 상기 제1용매는 당업계에서 통상적으로 사용할 수 있는 용매라면 제한 없이 사용할 수 있고, 바람직하게는 물 및 유기용매로 이루어진 군에서 선택된 1종 이상을 포함할 수 있고, 보다 바람직하게는 물 및 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종 이상을 포함할 수 있으며, 보다 더 바람직하게는 물, 농도가 15 ~ 45%인 C1 ~ C4의 알콜 및 농도가 55 ~ 85%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종 이상을 포함할 수 있고, 더욱 바람직하게는 물, 농도가 15 ~ 45%인 C1 ~ C4의 알콜 및 농도가 55 ~ 85%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종을 포함하며, 더욱 더 바람직하게는 물, 농도가 20 ~ 40%인 C1 ~ C4의 알콜 및 농도가 60 ~ 80%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종을 포함할 수 있다.In this case, the first solvent may be used without limitation as long as it is a solvent commonly used in the art, and may preferably include at least one selected from the group consisting of water and an organic solvent, more preferably water and It may include at least one selected from the group consisting of C1 to C4 alcohols, and more preferably water, C1 to C4 alcohols having a concentration of 15 to 45%, and C1 to C4 alcohols having a concentration of 55 to 85%. It may include at least one selected from the group consisting of alcohols, and more preferably from the group consisting of water, C1-C4 alcohols having a concentration of 15 to 45%, and C1-C4 alcohols having a concentration of 55 to 85%. may include one selected from the group consisting of water, C1 to C4 alcohol having a concentration of 20 to 40%, and C1 to C4 alcohol having a concentration of 60 to 80%. have.
또한, 상기 추출 방법 및 조건은 당업계에서 통상적으로 사용할 수 있는 천연 식물성 재료의 추출 방법 및 조건이라면 제한 없이 사용할 수 있음에 따라, 본 발명에서는 이를 특별히 한정하지 않는다.In addition, the extraction method and conditions are not particularly limited in the present invention, as they can be used without limitation as long as the extraction methods and conditions for natural vegetable materials that can be commonly used in the art are used.
한편, 상기 하수오 추출물을 제조하기 전에, 하수오 추출물의 제조가 더욱 용이하도록 상기 하수오를 전처리할 수 있다.On the other hand, before preparing the sewage extract, the sewage may be pre-treated so that the production of the sewage extract is easier.
상기 전처리는 수세, 분쇄 등을 수행할 수 있으며, 상기 수세 및 분쇄의 방법 및 조건은 당업계에서 통상적으로 사용할 수 있는 수세 및 분쇄의 방법 및 조건이라면 제한 없이 사용할 수 있음에 따라, 본 발명에서는 이를 특별히 한정하지 않는다.The pretreatment may be performed by washing with water, pulverizing, etc., and the method and conditions for washing and pulverizing can be used without limitation as long as the methods and conditions for washing and pulverizing are commonly used in the art. It is not particularly limited.
다음, 하수오 발효추출물에 대해 설명한다.Next, the fermented sewage extract will be described.
상기 하수오 발효추출물은 하수오 추출물을, 균주로 발효시켜서 제조할 수 있다.The fermented sewage extract may be prepared by fermenting the sewage extract into a strain.
상기 균주는 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 스트렙토코커스 써모필러스(Streptococcus thermophilus) 및 비피도박테리움 롱검(Bifidobacterium longum)으로 이루어진 군에서 선택된 1종 이상이고, 바람직하게는 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 스트렙토코커스 써모필러스(Streptococcus thermophilus) 및 비피도박테리움 롱검(Bifidobacterium longum)으로 이루어진 군에서 선택된 1종일 수 있다.The strain is at least one selected from the group consisting of Lactobacillus helveticus, Streptococcus thermophilus and Bifidobacterium longum, preferably Lactobacillus helveticus (Lactobacillus helveticus), Streptococcus thermophilus (Streptococcus thermophilus), and may be one selected from the group consisting of Bifidobacterium longum (Bifidobacterium longum).
이때, 상기 락토바실러스 헬베티쿠스(Lactobacillus helveticus)는 기탁번호가 KACC91148일 수 있고, 상기 스트렙토코커스 써모필러스(Streptococcus thermophilus)는 기탁번호가 KACC91147일 수 있으며, 상기 비피도박테리움 롱검(Bifidobacterium longum)은 기탁번호가 KACC91563일 수 있다.In this case, the Lactobacillus helveticus may have an accession number of KACC91148, and the Streptococcus thermophilus may have an accession number of KACC91147, and the Bifidobacterium longum) The accession number may be KACC91563.
본 발명에 따른 하수오 발효추출 조성물은 상술한 균주를 통해 하수오 추출물을 발효시킨 하수오 발효추출물을 유효성분으로 포함함에 따라, 항산화성이 현격히 우수한 효과를 발현할 수 있다.The fermented sewage extract composition according to the present invention contains, as an active ingredient, a fermented sewage extract obtained by fermenting the sewage extract through the above-mentioned strain, thereby exhibiting a remarkably excellent effect of antioxidant properties.
다음, 하수오 발효추출 조성물에 대해 설명한다.Next, a description will be given of the fermented sewage extract composition.
하수오 발효추출 조성물은 상술한 바와 같이 하수오 발효 추출물을 유효성분으로 포함한다.As described above, the fermented sewage extract composition includes the fermented sewage extract as an active ingredient.
이때, 상기 제1용매와 균주의 종류에 따라 하수오 발효추출 조성물에 구비되는 하수오 발효추출물의 농도가 상이할 수 있다.In this case, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition may be different depending on the type of the first solvent and the strain.
구체적으로, 상기 제1용매가 물이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus) 또는 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출 조성물은 상기 하수오 발효추출물을 30 ~ 420㎍/㎖의 농도로, 바람직하게는 40 ~ 400㎍/㎖의 농도로 포함할 수 있다. 만일 상기 제1용매가 물이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus) 또는 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출 조성물에 구비되는 상기 하수오 발효추출물의 농도가 30㎍/㎖ 미만이거나, 420㎍/㎖를 초과하면 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있을 수 있다.Specifically, when the first solvent is water, and the strain is Lactobacillus helveticus or Bifidobacterium longum, the sewage fermentation extract composition comprises 30 to 420 of the sewage fermentation extract. At a concentration of μg/ml, preferably, it may be included at a concentration of 40 to 400 μg/ml. If the first solvent is water and the strain is Lactobacillus helveticus or Bifidobacterium longum, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition is 30 If it is less than μg/ml or exceeds 420 μg/ml, there may be a problem in that antioxidant activity cannot be expressed at a desired level.
또한, 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus)인 경우, 상기 하수오 발효추출 조성물은 상기 하수오 발효추출물을 1 ~ 210㎍/㎖의 농도로, 바람직하게는 2 ~ 200㎍/㎖의 농도로 포함할 수 있다. 만일 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus)인 경우, 상기 하수오 발효추출 조성물에 구비되는 상기 하수오 발효추출물의 농도가 2㎍/㎖ 미만이거나, 200㎍/㎖를 초과하면 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있을 수 있다.In addition, when the first solvent is a C1 to C4 alcohol having a concentration of 15 to 45%, and the strain is Lactobacillus helveticus, the sewage fermentation extract composition contains 1 to 210 of the sewage fermentation extract. At a concentration of μg/ml, preferably, it may be included at a concentration of 2 to 200 μg/ml. If the first solvent is a C1-C4 alcohol having a concentration of 15 to 45%, and the strain is Lactobacillus helveticus, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition is If it is less than 2 μg/ml, or exceeds 200 μg/ml, there may be a problem in that antioxidant activity cannot be expressed at a desired level.
또한, 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 스트렙토코커스 써모필러스(Streptococcus thermophilus)인 경우, 상기 하수오 발효추출 조성물은 상기 하수오 발효추출물을 30 ~ 60㎍/㎖의 농도로, 바람직하게는 35 ~ 55㎍/㎖의 농도로 포함할 수 있다. 만일 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 스트렙토코커스 써모필러스(Streptococcus thermophilus)인 경우, 상기 하수오 발효추출 조성물에 구비되는 상기 하수오 발효추출물의 농도가 30㎍/㎖ 미만이거나, 60㎍/㎖를 초과하면 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있을 수 있다.In addition, when the first solvent is a C1 to C4 alcohol having a concentration of 15 to 45%, and the strain is Streptococcus thermophilus, the sewage fermentation extract composition contains 30 to 60% of the sewage fermented extract. It may be included at a concentration of μg/ml, preferably at a concentration of 35 to 55 μg/ml. If the first solvent is a C1-C4 alcohol having a concentration of 15 to 45%, and the strain is Streptococcus thermophilus, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition is If it is less than 30 μg/ml, or exceeds 60 μg/ml, there may be a problem in that antioxidant activity cannot be expressed at a desired level.
또한, 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출 조성물은 상기 하수오 발효추출물을 30 ~ 150㎍/㎖의 농도로, 바람직하게는 40 ~ 130㎍/㎖의 농도로 포함할 수 있다. 만일 상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출 조성물에 구비되는 상기 하수오 발효추출물의 농도가 30㎍/㎖ 미만이거나, 150㎍/㎖를 초과하면 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있을 수 있다.In addition, when the first solvent is a C1 to C4 alcohol having a concentration of 15 to 45%, and the strain is Bifidobacterium longum, the sewage fermentation extract composition is 30 ~ 150 At a concentration of ㎍ / ㎖, preferably 40 ~ 130㎍ / ㎖ may be included at a concentration. If the first solvent is a C1-C4 alcohol having a concentration of 15 to 45%, and the strain is Bifidobacterium longum, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition is If it is less than 30 μg/ml, or exceeds 150 μg/ml, there may be a problem in that antioxidant activity cannot be expressed at a desired level.
또한, 상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus)인 경우, 상기 하수오 발효추출 조성물은 상기 하수오 발효추출물을 3 ~ 8㎍/㎖의 농도로, 바람직하게는 4 ~ 7㎍/㎖의 농도로 포함할 수 있다. 만일 상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 락토바실러스 헬베티쿠스(Lactobacillus helveticus)인 경우, 상기 하수오 발효추출 조성물에 구비되는 상기 하수오 발효추출물의 농도가 3㎍/㎖ 미만이거나, 8㎍/㎖를 초과하면 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있을 수 있다.In addition, when the first solvent is an alcohol of C1 to C4 having a concentration of 55 to 85%, and the strain is Lactobacillus helveticus, the sewage fermentation extract composition contains 3 to 8 of the sewage fermentation extract. It may be included at a concentration of μg/ml, preferably at a concentration of 4 to 7 μg/ml. If the first solvent is a C1-C4 alcohol having a concentration of 55 to 85%, and the strain is Lactobacillus helveticus, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition is If it is less than 3 μg/ml, or exceeds 8 μg/ml, there may be a problem in that antioxidant activity cannot be expressed at a desired level.
그리고, 상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출 조성물은 상기 하수오 발효추출물을 80 ~ 130㎍/㎖의 농도로, 바람직하게는 85 ~ 120㎍/㎖의 농도로 포함할 수 있다. 만일 상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum)인 경우, 상기 하수오 발효추출 조성물에 구비되는 상기 하수오 발효추출물의 농도가 80㎍/㎖ 미만이거나, 130㎍/㎖를 초과하면 목적하는 수준으로 항산화성을 발현할 수 없는 문제가 있을 수 있다.And, when the first solvent is a C1 to C4 alcohol having a concentration of 55 to 85%, and the strain is Bifidobacterium longum, the sewage fermentation extract composition contains 80 to 130 of the sewage fermentation extract. It may be included at a concentration of μg/ml, preferably at a concentration of 85 to 120 μg/ml. If the first solvent is a C1-C4 alcohol having a concentration of 55 to 85%, and the strain is Bifidobacterium longum, the concentration of the sewage fermentation extract provided in the sewage fermentation extract composition is If it is less than 80 μg/ml, or exceeds 130 μg/ml, there may be a problem in that antioxidant activity cannot be expressed at a desired level.
한편, 상기 하수오 발효추출 조성물은, 하수오 발효추출물 외에, 제2용매;를 더 포함할 수 있다.On the other hand, the sewage fermentation extract composition, in addition to the sewage fermentation extract, a second solvent; may further include.
상기 제2용매는 당업계에서 통상적으로 후술하는 화장료 조성물, 건강 보조 식품 및 약?e적 조성물에 사용할 수 있는 용매라면 제한 없이 사용할 수 있고, 바람직하게는 물, 농도가 15 ~ 45%인 C1 ~ C4의 알콜 및 농도가 55 ~ 85%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종 이상을 포함할 수 있고, 보다 바람직하게는 물, 농도가 15 ~ 45%인 C1 ~ C4의 알콜 및 농도가 55 ~ 85%인 C1 ~ C4의 알콜로 이루어진 군에서 선택된 1종을 포함할 수 있다.The second solvent can be used without limitation as long as it is a solvent that can be used in cosmetic compositions, health supplements, and pharmaceutical compositions to be described later in the art, preferably water, C1 having a concentration of 15 to 45% may include at least one selected from the group consisting of C4 alcohol and C1 to C4 alcohol having a concentration of 55 to 85%, more preferably water, C1 to C4 alcohol having a concentration of 15 to 45%, and concentration It may include one selected from the group consisting of C1 to C4 alcohols having 55 to 85%.
본 발명에 따른 하수오 발효추출 조성물은, (1) 하수오를 제1용매를 통해 추출하여 하수오 추출물을 제조하는 단계; (2) 상기 하수오 추출물을 균주로 발효시켜서 하수오 발효추출물을 제조하는 단계; (3) 상기 하수오 발효추출물을 유효성분으로 포함하는 하수오 발효추출 조성물을 제조하는 단계;를 포함하여 제조된다.The sewage fermentation extract composition according to the present invention comprises the steps of: (1) extracting sewage water through a first solvent to prepare a sewage sewage extract; (2) preparing a fermented sewage extract by fermenting the sewage extract into a strain; (3) preparing a sewage fermentation extract composition comprising the sewage fermentation extract as an active ingredient; is prepared including.
이때, 상기 (1) 단계의 추출은 당업계에서 통상적으로 사용할 수 있는 추출 조건이라면 제한 없이 사용할 수 있으며, 바람직하게는 60 ~ 80℃에서 3 ~ 5시간 동안 처리하고, 3 ~ 5시간 동안 휴지시키는 공정을 2 ~ 5회 반복수행, 보다 바람직하게는 65 ~ 75℃에서 3.5 ~ 4.5시간 동안 처리하고, 3.5 ~ 4.5시간 동안 휴지시키는 공정을 2 ~ 4회 반복수행할 수 있으나, 이에 제한되는 것은 아니다.At this time, the extraction of step (1) can be used without limitation as long as it is an extraction condition that can be used commonly in the art, and is preferably treated at 60 to 80° C. for 3 to 5 hours, and rested for 3 to 5 hours. Repeating the process 2 to 5 times, more preferably treating at 65 to 75° C. for 3.5 to 4.5 hours, and resting for 3.5 to 4.5 hours may be repeated 2 to 4 times, but is not limited thereto .
또한, 상기 (2) 단계의 발효는 당업계에서 통상적으로 사용할 수 있는 발효 조건이라면 제한 없이 사용할 수 있고, 바람직하게는 온도 25 ~ 45℃에서 48 ~ 96시간 동안, 보다 바람직하게는 온도 30 ~ 40℃에서 55 ~ 89시간 동안 수행할 수 있다.In addition, the fermentation of step (2) can be used without limitation as long as it is a fermentation condition that can be used commonly in the art, preferably at a temperature of 25 to 45° C. for 48 to 96 hours, more preferably at a temperature of 30 to 40 It can be carried out at ℃ for 55 to 89 hours.
한편, 본 발명은 상술한 하수오 발효추출 조성물;을 유효성분으로 포함하는 화장료 조성물, 건강 보조 식품 및 약?e적 조성물을 각각 제공한다.On the other hand, the present invention provides a cosmetic composition, a health supplement and a pharmaceutical composition comprising the above-mentioned sewage fermented extract composition as an active ingredient, respectively.
상기 건강 보조 식품의 종류는 당업계의 통상적인 건강 보조식품이라면 제한되지 않으며, 일예로, 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알코올음료 및 비타민 복합제 등이 있으며, 환제, 분말, 과립, 침제, 정제, 캡슐 또는 음료인 형태로 사용할 수 있고 통상적인 의미에서의 건강 보조 식품을 모두 포함한다.The type of the health supplement is not limited as long as it is a conventional health supplement in the art, and for example, meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, ice cream, etc. There are dairy products, various soups, beverages, tea, drinks, alcoholic beverages and vitamin complexes, etc. include
상기 건강 보조 식품이 음료 조성물일 경우, 본 발명에 따른 하수오 발효추출 조성물을 함유하는 것 외에는 액체성분에는 특별한 제한은 없으며 통상의 음료와 같이 다양한 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.When the health supplement is a beverage composition, there is no particular limitation on the liquid component except that it contains the fermented sewage extract according to the present invention, and it may contain various flavoring agents or natural carbohydrates as additional components as in a conventional beverage. .
통상적으로, 건강기 보조 품에 포함되는 하수오 발효추출 조성물의 양은 전체 식품 중량의 0.01 ~ 20 중량%, 바람직하게는 0.01 ~ 10 중량%로 포함될 수 있다. 또한, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용할 수도 있다.In general, the amount of the fermented sewage extract included in the health supplements may be included in an amount of 0.01 to 20% by weight, preferably 0.01 to 10% by weight of the total food weight. In addition, in the case of long-term intake for the purpose of health and hygiene or health control, it may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
또한, 화장료 조성물로 제제화되는 경우, 상기 하수오 발효추출 조성물의 함량은 화장료 조성물 총 중량에 대하여 0.0001 내지 10 중량%이며, 바람직하게는 0.01 내지 5.0 중량%이다. 최소한의 자외선에 의한 피부 손상 개선 효과를 달성할 수 있도록 하수오 발효추출 조성물의 함량은 상기 최소치 이상인 것이 바람직하며, 과량 첨가에 따른 사용감 저하 및 각종 제형에의 적용 가능성을 고려하여 하수오 발효추출 조성물은 상기 최대치 이하인 것이 바람직하다. 이때, 상기 하수오 발효추출 조성물의 함량은 제형 또는 화장료 조성물에 함유되는 성분들의 함량에 따라 상기 범위 내에서 적절히 조절될 수 있다.In addition, when formulated as a cosmetic composition, the content of the fermentation extract composition is 0.0001 to 10% by weight, preferably 0.01 to 5.0% by weight, based on the total weight of the cosmetic composition. The content of the fermented sewage extract composition is preferably equal to or higher than the minimum value to achieve the skin damage improvement effect caused by minimal ultraviolet rays, and in consideration of the decrease in feeling of use due to excessive addition and the possibility of application to various formulations, the fermented sewage extract composition is It is preferably below the maximum. In this case, the content of the sewage fermentation extract composition may be appropriately adjusted within the above range according to the content of the ingredients contained in the formulation or cosmetic composition.
본 발명의 하수오 발효추출 조성물 및 이의 제조방법은 소정의 균주를 통한 발효로 인해 항산화성이 현저히 우수한 효과를 발현할 수 있다.The fermented sewage extract composition of the present invention and a method for producing the same can express a remarkably excellent effect of antioxidant properties due to fermentation through a predetermined strain.
하기의 실시예를 통하여 본 발명을 더욱 구체적으로 설명하기로 하지만, 하기 실시예가 본 발명의 범위를 제한하는 것은 아니며, 이는 본 발명의 이해를 돕기 위한 것으로 해석되어야 할 것이다.The present invention will be described in more detail through the following examples, but the following examples are not intended to limit the scope of the present invention, which should be construed to aid understanding of the present invention.
[실시예][Example]
실시예 1: 하수오 발효추출 조성물의 제조Example 1: Preparation of Sewage Fermentation Extraction Composition
(1) 하수오 추출물의 제조(1) Preparation of sewage extract
하수오를 제1용매로 물에 추출하되, 온도 70℃에서 4시간동안 처리하고, 4시간 휴지시키는 공정을 4회 반복수행한 후, 추출에 사용된 제1용매를 진공 여과법을 통해 제거하여 하수오 추출물을 제조하였다.After extracting sewage water with the first solvent into water, treating at 70° C. for 4 hours, and resting for 4 hours 4 times, the first solvent used for extraction is removed through vacuum filtration to extract sewage. was prepared.
(2) 하수오 발효추출물의 제조(2) Preparation of fermented sewage extract
비피도박테리움 롱검(Bifidobacterium longum) 균주(기탁번호: KACC91563)를 상기 제조한 하수오 추출물에 접종하고 35±2℃에서 72시간 동안 발효시켜서 하수오 발효추출물을 수득하였다.Bifidobacterium longum (Bifidobacterium longum) strain (Accession No.: KACC91563) was inoculated into the prepared sewage extract and fermented at 35±2° C. for 72 hours to obtain a sewage fermented extract.
(3) 하수오 발효추출 조성물의 제조(3) Preparation of a composition for extracting sewage fermented water
제조한 하수오 발효추출물을 제2용매로 증류수에 희석하여 하수오 발효추출물의 농도가 40㎍/㎖가 되도록 하수오 발효추출 조성물을 제조하였다.The prepared sewage fermentation extract was diluted in distilled water as a second solvent to prepare a sewage fermentation extract composition so that the concentration of the sewage fermentation extract was 40 μg/ml.
실시예 2 ~ 36Examples 2 to 36
실시예 1과 동일하게 실시하되, 제1용매와 제2용매의 종류, 균주의 종류, 하수오 발효추출 조성물에서 하수오 발효추출물의 농도 등의 달리하여, 하기 표 1 및 표 2와 같이 하수오 발효추출 조성물을 제조하였다.The same procedure as in Example 1, except that the type of the first solvent and the second solvent, the type of strain, and the concentration of the sewage fermented extract in the sewage fermentation extract composition were different, as shown in Tables 1 and 2 below. was prepared.
비교예 1 ~ 12Comparative Examples 1 to 12
실시예1과 동일하게 실시하되, 하수오 추출물을 발효하지 않고, 하수오 추출물을 제2용매와 혼합하는 방법으로, 제1용매와 제2용매의 종류와 하수오 발효추출 조성물의 하수오 추출물의 농도를 달리하여 하기 표 1 및 표 2와 같이 하수오 발효추출 조성물을 제조하였다.In the same manner as in Example 1, except that the sewage extract is mixed with the second solvent without fermenting the sewage extract, the types of the first solvent and the second solvent and the concentration of the sewage extract of the sewage fermented extract composition are different. As shown in Tables 1 and 2 below, a composition for extracting sewage ferment was prepared.
이때, 하기에서 사용한 균주인 락토바실러스 헬베티쿠스(Lactobacillus helveticus)는 기탁번호가 KACC91148이고, 스트렙토코커스 써모필러스(Streptococcus thermophilus)는 기탁번호가 KACC91147이다.At this time, Lactobacillus helveticus, which is a strain used below, has an accession number of KACC91148, and Streptococcus thermophilus has an accession number of KACC91147.
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
1Example
One
13Example
13
주정
2Example
2
14Example
14
주정
spirits
3Example
3
15Example
15
주정
spirits
4Example
4
16Example
16
주정
spirits
5Example
5
17Example
17
주정
6Example
6
18Example
18
주정
spirits
7Example
7
19Example
19
주정
spirits
8Example
8
20Example
20
주정
spirits
9Example
9
21Example
21
주정
10Example
10
22Example
22
주정
spirits
11Example
11
23Example
23
주정
spirits
12Example
12
24Example
24
주정
spirits
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
25Example
25
주정Concentration 70%
1comparative example
One
26Example
26
주정Concentration 70%
spirits
2comparative example
2
27Example
27
주정Concentration 70%
spirits
3comparative example
3
28Example
28
주정Concentration 70%
spirits
4comparative example
4
29Example
29
주정Concentration 70%
spirits
5comparative example
5
주정
spirits
30Example
30
주정Concentration 70%
spirits
6comparative example
6
주정
spirits
31Example
31
주정Concentration 70%
spirits
7comparative example
7
주정
spirits
32Example
32
주정Concentration 70%
spirits
8comparative example
8
주정
spirits
33Example
33
주정Concentration 70%
9comparative example
9
주정Concentration 70%
spirits
34Example
34
주정Concentration 70%
spirits
10comparative example
10
주정Concentration 70%
spirits
35Example
35
주정Concentration 70%
spirits
11comparative example
11
주정Concentration 70%
spirits
36Example
36
주정Concentration 70%
spirits
12comparative example
12
주정Concentration 70%
spirits
<실험예 1><Experimental Example 1>
상기 실시예 1 ~ 36 및 비교예 1 ~ 12에 대해 하기 항목에 대하여 측정/평가하여 도 1 내지 도 3에 나타내었다.Examples 1 to 36 and Comparative Examples 1 to 12 were measured/evaluated for the following items and shown in FIGS. 1 to 3 .
1. DPPH 자유 라디칼 소거활성 측정1. Measurement of DPPH free radical scavenging activity
상기 실시예 1 ~ 36 및 비교예 1 ~ 12에 따라 제조한 하수오 발효추출 조성물에 대하여, DPPH 자유 라디칼 소거활성 측정을 평가하였다.For the sewage fermentation extract compositions prepared according to Examples 1 to 36 and Comparative Examples 1 to 12, the measurement of DPPH free radical scavenging activity was evaluated.
상기 실시예 1 ~ 36 및 비교예 1 ~ 12에 따라 제조한 하수오 발효추출 조성물을 1㎖ 씩 준비하고, standard로 사용되는 BHT 용액은 BHT 10mg을 메탄올(methanol) 1㎖로 희석하여 상기 실시예 1 ~ 36 및 비교예 1 ~ 12와 동일한 농도로 각각 1㎖ 씩 제조하였다. DPPH 용액은 DPPH 0.002gdp 메탄올 25㎖를 혼합하여 제조하였다.1 ml of the sewage fermentation extract composition prepared according to Examples 1 to 36 and Comparative Examples 1 to 12 was prepared, and for the BHT solution used as a standard, 10 mg of BHT was diluted with 1 ml of methanol in Example 1 ~ 36 and Comparative Examples 1 to 12 were prepared at the same concentration as 1 ml each. The DPPH solution was prepared by mixing 25 ml of DPPH 0.002 gdp methanol.
그리고, 96 well plate에 BHT용액과 메탄올을 각각 80 mL씩 혼합한 군, BHT와 DPPH 용액을 각각 80 mL씩 혼합한 군, 시료와 DPPH 용액을 각각 80 mL씩 혼합한 군, 메탄올과 DPPH용액을 각각 80 mL씩 혼합한 군, 메탄올만을 160 mL씩 처리한 군, 증류수와 DPPH용액을 각각 80 mL씩 혼합한 군, 증류수와 메탄올을 각각 80 mL씩 혼합한 군을 각각 구분하여 분주한 후 빛과 반응하지 못하게 foil로 감싸준 뒤 실온에서 30분간 방치하였다. ELISA reader를 이용해 517㎚에서 흡광도를 측정하였다.Then, in a 96 well plate, a group in which 80 mL of BHT solution and methanol were mixed, 80 mL each of BHT and DPPH solution, 80 mL each of sample and DPPH solution, and methanol and DPPH solution Separately and dispense into a group in which 80 mL of each was mixed, 160 mL of methanol alone, 80 mL of distilled water and DPPH solution, and 80 mL of distilled water and methanol, respectively. After wrapping with foil to prevent reaction, it was left at room temperature for 30 minutes. Absorbance was measured at 517 nm using an ELISA reader.
흡광도 측정기기(ELISA reader)를 이용하여 517㎚에서 흡광도를 측정하였다.Absorbance was measured at 517 nm using an absorbance measuring instrument (ELISA reader).
그리고, 측정한 흡광도를 통해 실시예 1 ~ 36 중 비교예 1 ~ 12와 동일 농도를 가지는 각각의 실시예에 대하여, 비교예 1 ~ 12에 대비한 DPPH 자유 라디칼 소거 활성 향상 정도를 하기 수학식 1에 따라 계산하여, 그 결과를 도 1 내지 도 3에 나타내었다.And, for each Example having the same concentration as Comparative Examples 1 to 12 among Examples 1 to 36 through the measured absorbance, the degree of improvement in the DPPH free radical scavenging activity compared to Comparative Examples 1 to 12 was calculated using the following Equation 1 , and the results are shown in FIGS. 1 to 3 .
[수학식 1][Equation 1]
상기 수학에서, R, RA, RB는 각각 라디칼 소거능 증가율, 실시예에 따른 조성물의 라디칼 소거능, 비교예에 따른 조성물의 라디칼 소거능이다.In the mathematical, R, R A, R B is a radical scavenging activity of the composition of the radical scavenging activity, in Comparative Examples of the composition of the respective radical scavenging rate, the embodiment.
측정결과, 도 1에 도시된 바와 같이 제1용매로 물을 사용한 실시예 1 ~ 12중, 실시예 1 ~ 8의 DPPH 자유 라디칼 소거능이 현격히 우수하고, 도 2에 도시된 바와 같이 제1용매로 농도 30%의 주정을 사용한 실시예 13 ~ 24 중 실시예 13, 14, 17 ~ 19 및 21의 DPPH 자유 라디칼 소거능이 현격히 우수하며, 도 3에 도시된 바와 같이 제1용매로 농도 70%의 주정을 사용한 실시예 25 ~ 36 중 실시예 26의 DPPH 자유 라디칼 소거능이 현격히 우수함에 따라 항산화성이 현저히 우수한 것을 확인할 수 있다.As a result of the measurement, the DPPH free radical scavenging ability of Examples 1 to 8 among Examples 1 to 12 using water as the first solvent as shown in FIG. 1 was remarkably excellent, and as shown in FIG. The DPPH free radical scavenging ability of Examples 13, 14, 17 to 19 and 21 among Examples 13 to 24 using alcohol having a concentration of 30% was remarkably excellent, and as shown in FIG. 3, alcohol having a concentration of 70% as the first solvent As the DPPH free radical scavenging ability of Example 26 was remarkably excellent among Examples 25 to 36 using
실시예 37 ~ 실시예 63Example 37-Example 63
실시예 1과 동일하게 실시하여 제조하되, 제2용매로 농도 50%의 에탄올을 사용하고, 제1용매와 제2용매의 종류, 균주의 종류, 하수오 발효추출 조성물에서 하수오 발효추출물의 농도 등의 달리하여, 하기 표 3 및 표 4와 같이 하수오 발효추출 조성물을 제조하였다.It was prepared in the same manner as in Example 1, except that ethanol having a concentration of 50% was used as the second solvent, and the type of the first solvent and the second solvent, the type of the strain, the concentration of the sewage fermentation extract in the sewage fermentation extract composition, etc. Alternatively, as shown in Tables 3 and 4 below, a composition for extracting sewage fermented water was prepared.
비교예 13 ~ 22Comparative Examples 13 to 22
비교예 1과 동일하게 실시하여 제조하되, 제2용매로 농도 50%의 에탄올을 사용하고, 제1용매와 제2용매의 종류, 균주의 종류, 하수오 발효추출 조성물에서 하수오 발효추출물의 농도 등의 달리하여, 하기 표 3 및 표 4와 같이 하수오 발효추출 조성물을 제조하였다.It was prepared in the same manner as in Comparative Example 1, except that ethanol having a concentration of 50% was used as the second solvent, and the type of the first solvent and the second solvent, the type of the strain, the concentration of the sewage fermentation extract in the sewage fermentation extract composition, etc. Alternatively, as shown in Tables 3 and 4 below, a composition for extracting sewage fermented water was prepared.
이때, 하기에서 사용한 균주인 락토바실러스 헬베티쿠스(Lactobacillus helveticus)는 기탁번호가 KACC91148이고, 스트렙토코커스 써모필러스(Streptococcus thermophilus)는 기탁번호가 KACC91147이다.At this time, Lactobacillus helveticus, which is a strain used below, has an accession number of KACC91148, and Streptococcus thermophilus has an accession number of KACC91147.
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
37Example
37
46Example
46
주정
spirits
38Example
38
47Example
47
주정
39Example
39
48Example
48
주정
40Example
40
49Example
49
주정
spirits
41Example
41
50Example
50
주정
42Example
42
51Example
51
주정
43Example
43
52Example
52
주정
spirits
44Example
44
53Example
53
주정
45Example
45
54Example
54
주정
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
종류first/second solvent
Kinds
(㎍/㎖)density
(μg/ml)
55Example
55
주정Concentration 70%
spirits
13comparative example
13
56Example
56
주정Concentration 70%
14comparative example
14
57Example
57
주정Concentration 70%
15comparative example
15
58Example
58
주정Concentration 70%
spirits
16comparative example
16
주정
spirits
59Example
59
주정Concentration 70%
17comparative example
17
주정
spirits
60Example
60
주정Concentration 70%
spirits
18comparative example
18
주정
spirits
61Example
61
주정Concentration 70%
spirits
19comparative example
19
주정Concentration 70%
spirits
62Example
62
주정Concentration 70%
20comparative example
20
주정Concentration 70%
spirits
63Example
63
주정Concentration 70%
21comparative example
21
주정Concentration 70%
spirits
<실험예 2><Experimental Example 2>
상기 실시예 37 ~ 63 및 비교예 13 ~ 21에 대해 하기 항목에 대하여 측정/평가하여 도 4 내지 도 6에 나타내었다.Examples 37 to 63 and Comparative Examples 13 to 21 were measured/evaluated for the following items and shown in FIGS. 4 to 6 .
1. ABTS 라디칼 소거활성 측정1. Measurement of ABTS radical scavenging activity
상기 실시예 37 ~ 63 및 비교예 13 ~ 21에 따라 제조한 하수오 발효추출 조성물에 대하여, ABTS 라디칼 소거활성 측정을 평가하였다.ABTS radical scavenging activity was evaluated for the fermented sewage extract compositions prepared according to Examples 37 to 63 and Comparative Examples 13 to 21.
구체적으로, 7 mM ABTS와 140 mM 과황산칼륨(potassium persulfate) 용액을 혼합하고, 24시간 동안 암실에 방치한 후, 734㎚에서 흡광도 값이 0.7±0.02가 되도록 농도 50%의 에탄올로 희석한 후, 실시예 37 ~ 63 및 비교예 13 ~ 21에 따라 제조한 하수오 발효추출 조성물 50μL를 가하여 흡광도의 변화를 정확히 3분 후에 측정하였으며, 하기 수학식 2에 의해 ABTS 라디칼 소거 활성(%)을 환산하여, 대조군에 대한 흡광도 감소율을 측정함으로써 ABTS 라디칼 소거 활성(%)을 측정하였다.Specifically, 7 mM ABTS and 140 mM potassium persulfate solution were mixed, left in the dark for 24 hours, and then diluted with ethanol at a concentration of 50% so that the absorbance value at 734 nm was 0.7 ± 0.02. , Examples 37 to 63 and Comparative Examples 13 to 21 by adding 50 μL of the fermentation extract composition prepared in accordance with the absorbance was measured exactly 3 minutes later, ABTS radical scavenging activity (%) by the following Equation 2 was converted to , ABTS radical scavenging activity (%) was measured by measuring the absorbance reduction rate relative to the control.
[수학식 2][Equation 2]
ABTS 라디칼 소거활성(%)={1-(시료 흡광도/대조군 흡광도)}×100ABTS radical scavenging activity (%) = {1- (sample absorbance / control absorbance)} × 100
그리고, 실시예 37 ~ 63 중 비교예 13 ~ 21과 동일 농도를 가지는 각각의 실시예에 대하여, 비교예 13 ~ 21에 대비한 ABTS 라디칼 소거 활성 향상 정도를 도 4 내지 도 6에 나타내었다.And, for each Example having the same concentration as Comparative Examples 13 to 21 among Examples 37 to 63, the degree of improvement in ABTS radical scavenging activity compared to Comparative Examples 13 to 21 is shown in FIGS. 4 to 6 .
측정결과, 도 4에 도시된 바와 같이 제1용매로 물을 사용한 실시예 37 ~ 45중, 실시예 41의 ABTS 라디칼 소거능이 현격히 우수하고, 도 5에 도시된 바와 같이 제1용매로 농도 30%의 주정을 사용한 실시예 46 ~ 54 중 실시예 49 ~ 51의 ABTS 라디칼 소거능이 현격히 우수하며, 도 6에 도시된 바와 같이 제1용매로 농도 70%의 주정을 사용한 실시예 55 ~ 63 중 실시예 59의 ABTS 라디칼 소거능이 현격히 우수함에 따라 항산화성이 현저히 우수한 것을 확인할 수 있다.As a result of the measurement, as shown in FIG. 4, among Examples 37 to 45 using water as the first solvent, the ABTS radical scavenging ability of Example 41 was remarkably excellent, and as shown in FIG. 5, the concentration of 30% as the first solvent The ABTS radical scavenging ability of Examples 49 to 51 among Examples 46 to 54 using the alcohol of As the ABTS radical scavenging ability of 59 is remarkably excellent, it can be confirmed that the antioxidant properties are remarkably excellent.
이하, 본 발명에 따른 하수오 발효추출 조성물을 유효성분으로 포함하는 제조예에 대하여 나타내도록 하겠으나, 이는 본 발명은 구체적으로 설명하기 위한 것일뿐이며, 이에 한정되는 것은 아니다.Hereinafter, although it will be shown with respect to a manufacturing example comprising the fermented sewage extract composition according to the present invention as an active ingredient, the present invention is only intended to be described in detail, and is not limited thereto.
제조예 1: 하수오 발효추출 조성물을 유효성분으로 포함하는 건강 보조 식품의 제조Preparation Example 1: Preparation of a health supplement comprising the fermented sewage extract composition as an active ingredient
하수오 발효추출 조성물 200 ㎎Sauerkraut fermented extract composition 200 mg
비타민 A 아세테이트 70 ㎍70 μg vitamin A acetate
비타민 E 1.0 ㎎Vitamin E 1.0 mg
비타민 B 1 0.13 ㎎Vitamin B 1 0.13 mg
비타민 B 2 0.15 ㎎Vitamin B 2 0.15 mg
비타민 B 6 0.5㎎Vitamin B 6 0.5mg
비타민 B 12 0.2 ㎍0.2 μg of vitamin B 12
비타민 C 10 ㎎
비오틴10 ㎍Biotin 10 μg
니코틴산아미드 1.7 ㎎Nicotinamide 1.7 mg
엽산 50 ㎍50 μg folic acid
판토텐산 칼슘 0.5 ㎎Calcium pantothenate 0.5 mg
황산제1철 1.75 ㎎Ferrous sulfate 1.75 mg
산화아연 0.82 ㎎Zinc oxide 0.82 mg
탄산마그네슘 25.3 ㎎Magnesium carbonate 25.3 mg
제1인산칼륨 15 ㎎Potassium monophosphate 15 mg
제2인산칼슘 55 ㎎Dibasic calcium phosphate 55 mg
구연산칼륨 90 ㎎Potassium citrate 90 mg
탄산칼슘 100 ㎎Calcium carbonate 100 mg
염화마그네슘 24.8 ㎎Magnesium chloride 24.8 mg
제조예 2: 하수오 발효추출 조성물을 유효성분으로 포함하는 화장료 조성물의 제조Preparation Example 2: Preparation of a cosmetic composition comprising a sewage fermentation extract composition as an active ingredient
하수오 발효추출 조성물: 1중량%Sauerkraut fermentation extract composition: 1% by weight
친유형 모노스테아린산글리세린: 2중량%Lipophilic glycerin monostearate: 2% by weight
세테아릴알콜: 2중량%Cetearyl alcohol: 2% by weight
스테아린산: 1.5중량%Stearic acid: 1.5 wt%
폴리솔베이트 60: 1.5중량%Polysorbate 60: 1.5 wt%
솔비탄스테아레이트: 0.6중량%Sorbitan Stearate: 0.6 wt%
하이드로제네이티드 폴리이소부텐: 1중량%Hydrogenated polyisobutene: 1% by weight
스쿠알란: 3중량%Squalane: 3% by weight
광물유: 5중량%Mineral oil: 5% by weight
사이클로메치콘: 5중량%Cyclomethicone: 5% by weight
디메치콘: 1중량%Dimethicone: 1 wt%
초산토코페롤: 0.5중량%Tocopherol acetate: 0.5 wt%
글리세린: 5중량%Glycerin: 5% by weight
베타인: 3중량%Betaine: 3% by weight
트리에탄올아민: 1중량%Triethanolamine: 1% by weight
산탄검: 0.05중량%Xanthan Gum: 0.05% by weight
향: 적량Fragrance: Appropriate amount
방부제: 적량Preservative: Appropriate amount
색소: 적량Color: Appropriate amount
증류수: 잔량Distilled water: remaining
이상에서 본 발명의 일 실시 예에 대하여 설명하였으나, 본 발명의 사상은 본 명세서에 제시되는 실시 예에 제한되지 아니하며, 본 발명의 사상을 이해하는 당업자는 동일한 사상의 범위 내에서, 구성요소의 부가, 변경, 삭제, 추가 등에 의해서 다른 실시 예를 용이하게 제안할 수 있을 것이나, 이 또한 본 발명의 사상범위 내에 든다고 할 것이다.Although one embodiment of the present invention has been described above, the spirit of the present invention is not limited to the embodiments presented herein, and those skilled in the art who understand the spirit of the present invention can add components within the scope of the same spirit. , changes, deletions, additions, etc. will be able to easily suggest other embodiments, but this will also fall within the scope of the present invention.
Claims (11)
상기 제1용매가 물이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum, KACC91563)인 경우,
상기 하수오 발효추출물을 30 ~ 420㎍/㎖의 농도로 포함하는 하수오 발효추출 조성물.According to claim 1,
When the first solvent is water and the strain is Bifidobacterium longum (KACC91563),
Sewage fermentation extract composition comprising the sewage fermentation extract at a concentration of 30 ~ 420㎍ / ㎖.
상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 스트렙토코커스 써모필러스(Streptococcus thermophilus, KACC91147)인 경우,
상기 하수오 발효추출물을 30 ~ 60㎍/㎖의 농도로 포함하는 하수오 발효추출 조성물.According to claim 1,
When the first solvent is a C1-C4 alcohol having a concentration of 15 to 45%, and the strain is Streptococcus thermophilus (KACC91147),
A sewage fermentation extract composition comprising the sewage fermentation extract at a concentration of 30 to 60 μg/ml.
상기 제1용매가 농도가 15 ~ 45%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum, KACC91563)인 경우,
상기 하수오 발효추출물을 30 ~ 150㎍/㎖의 농도로 포함하는 하수오 발효추출 조성물.According to claim 1,
When the first solvent is a C1-C4 alcohol having a concentration of 15 to 45%, and the strain is Bifidobacterium longum (KACC91563),
Sewage fermentation extract composition comprising the sewage fermentation extract at a concentration of 30 ~ 150㎍ / ㎖.
상기 제1용매가 농도가 55 ~ 85%인 C1 ~ C4의 알콜이고, 상기 균주가 비피도박테리움 롱검(Bifidobacterium longum, KACC91563)인 경우,
상기 하수오 발효추출물을 80 ~ 130㎍/㎖의 농도로 포함하는 하수오 발효추출 조성물.According to claim 1,
When the first solvent is a C1 to C4 alcohol having a concentration of 55 to 85%, and the strain is Bifidobacterium longum (KACC91563),
A sewage fermentation extract composition comprising the sewage fermentation extract at a concentration of 80 to 130 μg/ml.
상기 발효는 온도 25 ~ 45℃에서 35 ~ 61시간 동안 수행하는 하수오 발효추출 조성물.According to claim 1,
The fermentation is performed for 35 to 61 hours at a temperature of 25 ~ 45 ℃ Sewage fermentation extract composition.
(2) 상기 하수오 추출물을 스트렙토코커스 써모필러스(Streptococcus thermophilus, KACC91147) 및 비피도박테리움 롱검(Bifidobacterium longum, KACC91563)으로 이루어진 군에서 선택된 1종 이상을 포함하는 균주로 발효시켜서 하수오 발효추출물을 제조하는 단계;
(3) 상기 하수오 발효추출물을 유효성분으로 포함하는 하수오 발효추출 조성물을 제조하는 단계;를 포함하는 하수오 발효추출 조성물 제조방법.(1) Sewage is extracted through a first solvent containing one selected from the group consisting of water, C1 to C4 alcohols with a concentration of 15 to 45%, and C1 to C4 alcohols with a concentration of 55 to 85%. preparing an extract;
(2) fermenting the sewage extract into a strain containing at least one selected from the group consisting of Streptococcus thermophilus (KACC91147) and Bifidobacterium longum (KACC91563) to prepare a sewage fermented extract to do;
(3) preparing a sewage fermentation extract composition comprising the sewage fermentation extract as an active ingredient; a method for producing a sewage fermentation extract composition comprising a.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200151783A KR102298782B1 (en) | 2018-12-07 | 2020-11-13 | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180157261A KR102212517B1 (en) | 2018-12-07 | 2018-12-07 | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof |
KR1020200151783A KR102298782B1 (en) | 2018-12-07 | 2020-11-13 | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180157261A Division KR102212517B1 (en) | 2018-12-07 | 2018-12-07 | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200130801A KR20200130801A (en) | 2020-11-20 |
KR102298782B1 true KR102298782B1 (en) | 2021-09-07 |
Family
ID=73697161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200151783A KR102298782B1 (en) | 2018-12-07 | 2020-11-13 | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102298782B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11439118B2 (en) | 2019-04-03 | 2022-09-13 | Mje, Llc | System and method for securing calf hutches |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1288119B1 (en) * | 1996-06-28 | 1998-09-10 | Renata Maria Anna Ve Cavaliere | DIETARY COMPOSITIONS TO BE USED IN FEEDING VIA ENTERICA |
KR20040063291A (en) | 2003-01-06 | 2004-07-14 | 에스케이케미칼주식회사 | Preparation method of Polygonum multiflorum Thunb extracts and pharmaceutical composition for diabetes therapeutics using thereof |
KR100981344B1 (en) * | 2008-04-02 | 2010-09-10 | (주)더페이스샵 | The cosmetic composition for preventing the skin aging |
KR101521754B1 (en) * | 2014-05-09 | 2015-05-19 | 주식회사 엘지생활건강 | Cosmetic composition having antioxidation activity |
KR101732904B1 (en) * | 2015-06-11 | 2017-05-08 | 주식회사 아미코스메틱 | Cosmetic compositions for cooling and soothing skincontaining polygonum multiflorum extract, fermented pseudo alteromonas extract, saccharomyses lysate extract and portulaca oleracea extract |
-
2020
- 2020-11-13 KR KR1020200151783A patent/KR102298782B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
농림부 최종연구보고서, "하수오를 이용한 고품질의 가공제품" (2003) 1부.* |
Also Published As
Publication number | Publication date |
---|---|
KR20200130801A (en) | 2020-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101566320B1 (en) | Cosmetic composition comprising an Impatiens balsamina L, Maca, Rosa multiflora Thunberg, Eryobotrya japonica and Pachyrrhizus erosus Complex-fermented extract | |
KR102356423B1 (en) | Composition Comprising Complex Strain with Anti-microbial, Skin Moisturizing, Anti-atopy, Skin Barrier, and Anti-wrinkle Property as Active Ingredient | |
KR102298782B1 (en) | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof | |
KR102212517B1 (en) | Polygonum multiflorum Thunberg fermented Extract composition and manufacturing method thereof | |
JP2009107965A (en) | Ceramide synthesis promoter, and external preparation for skin and food and drink | |
KR102396588B1 (en) | Antioxidant composition containing femented Rubus coreanus extract | |
KR102294278B1 (en) | Antioxidant composition containing femented mulberry extract | |
KR102185437B1 (en) | Antioxidant composition containing femented Rubus coreanus extract | |
KR20200057126A (en) | Composition for Regenerating Skin and Enhancing Hair Growth Comprising Apigenin | |
KR20110044966A (en) | Compositions for antioxidation | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR101855837B1 (en) | Food Composition Comprising Microalgae and The Preparation Method thereof | |
KR101447007B1 (en) | Composition for antiaging comprising the extract of Dipterocarpus obtusifolius Teijsm. Ex Miq. as an active ingredient | |
KR102189326B1 (en) | Composition comprising lava seawater mineral water for promoting beneficial bacteria and suppressing harmful bacteria and method for manufacturing the same | |
KR102330009B1 (en) | Lactobacillus paracasei JSKIU 12-9 (KCTC18805P) from fermented local food in Jeju and composition with the function of anti-aging, anti-cancer and anti-dental caries thereof | |
KR102331207B1 (en) | Antioxidant composition containing femented Rubus coreanus extract | |
KR101525090B1 (en) | Cosmetic Composition for skin Whitening | |
KR102106440B1 (en) | Composition for improving skin condition comprising blueberry and black rice extract fermented lactic acid bacteria | |
KR102185438B1 (en) | Antioxidant composition containing femented mulberry extract | |
KR102014961B1 (en) | Composition for anti oxidation containing extract of soybean pod | |
KR102214621B1 (en) | Functional food composition containing black kelp | |
KR20200084215A (en) | Anti-inflammatory composition comprising extract of Polyopes affinis | |
KR102014960B1 (en) | Composition for anti oxidation containing extract of soybean root | |
KR102175244B1 (en) | antioxidant composition comprising Astragalus membranaceus and method of manufacturing the same | |
KR102029585B1 (en) | A moisturizing, anti-inflammatory and anti-allergic cosmetic composition comprising mixed fermented extracts of 3 kinds of food materials and preparation method of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |